drugset / Trial / NCT06845254
Clinical Study on the Intervention of Xuesaitong Soft Capsules in Post-Intervention Patients with Acute Coronary Syndrome and Clinical Research Protocol
Phase 3
Not yet recruiting
400 enrolled
Xiyuan Hospital of China Academy of Chinese Medical Sciences
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the effects of Xuesaitong soft capsules on platelet function, clinical efficacy, prognosis, and safety in the treatment of acute coronary syndrome, 400 patients with acute coronary syndrome who underwent PCI were treated with Xuesaitong soft capsules (mainly containing ginsenosides) for 12 weeks.
Timeline
- Start
- 2025-03-01
- Primary completion
- 2025-10-01
- Completion
- 2026-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Panax notoginseng saponins | Traditional medicine (herbal / TCM) | 0.33 g | — |